Progyny, Inc.
PGNY
$25.86
$0.381.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.29B | 1.29B | 1.27B | 1.24B | 1.21B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.29B | 1.29B | 1.27B | 1.24B | 1.21B |
| Cost of Revenue | 981.37M | 984.18M | 977.65M | 964.52M | 946.43M |
| Gross Profit | 311.76M | 304.48M | 291.04M | 277.44M | 266.75M |
| SG&A Expenses | 207.57M | 211.51M | 205.19M | 200.67M | 193.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.19B | 1.20B | 1.18B | 1.17B | 1.14B |
| Operating Income | 104.19M | 92.98M | 85.84M | 76.77M | 73.10M |
| Income Before Tax | 105.78M | 95.43M | 95.24M | 89.23M | 87.22M |
| Income Tax Expenses | 38.09M | 36.91M | 38.67M | 36.11M | 34.73M |
| Earnings from Continuing Operations | 67.69 | 58.52 | 56.57 | 53.12 | 52.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 67.69M | 58.52M | 56.57M | 53.12M | 52.50M |
| EBIT | 104.19M | 92.98M | 85.84M | 76.77M | 73.10M |
| EBITDA | 109.51M | 97.93M | 90.29M | 80.79M | 76.67M |
| EPS Basic | 0.81 | 0.68 | 0.66 | 0.61 | 0.59 |
| Normalized Basic EPS | 0.84 | 0.75 | 0.69 | 0.62 | 0.57 |
| EPS Diluted | 0.77 | 0.65 | 0.63 | 0.59 | 0.57 |
| Normalized Diluted EPS | 0.80 | 0.72 | 0.66 | 0.60 | 0.55 |
| Average Basic Shares Outstanding | 337.94M | 342.52M | 343.09M | 347.14M | 355.24M |
| Average Diluted Shares Outstanding | 354.08M | 358.64M | 358.09M | 361.68M | 369.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |